Moreover, JNK signaling is also inhibited by phosphorylation of MAP2K4 by AKT (Park et al., 2002) in breast tumors with AKT activation caused by ‘driver’ mutations in PTEN or PIK3CA (Garraway and Lander, 2013). This evidence concerns the gene AKT1 and breast neoplasm.